News + Resources
Keep up with the latest
Featured
Recent
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
This Scientist Is Building Custom Gene-Editing Tools
November 11, 2024
This Scientist Is Building Custom Gene-Editing Tools
November 11, 2024
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
All Stories
News
The New Age of CRISPR
April 11, 2023
Biotechnology Innovation Organization
Read Now
Press
The New Age of CRISPR
April 11, 2023
Biotechnology Innovation Organization
Read Now
News
Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
March 31, 2023
Read Now
Press
Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
March 31, 2023
Read Now
News
Industry appetite for natural killer cells intensifies
February 15, 2023
Nature
Read Now
Press
Industry appetite for natural killer cells intensifies
February 15, 2023
Nature
Read Now
News
Economic Forecast 2023
January 6, 2023
San Francisco Business Times
Read Now
Press
Economic Forecast 2023
January 6, 2023
San Francisco Business Times
Read Now